Autonomix names Brad Hauser CEO; grants 900k-share inducement option; Bisson becomes Vice Chair

Autonomix Medical, Inc.

Brad Hauser appointed CEO and President; base salary $450,000, target bonus 60%.
Hauser receives 10-year option for 900,000 shares at closing price on June 17, vesting over 4 years.
Lori Bisson steps down as CEO, appointed Executive Vice Chair and Strategic Adviser; base salary $150,000, target bonus 50%.
Bisson continues vesting in prior options and forfeits severance in connection with the role change.
Inducement options granted outside 2023 Stock Plan per Nasdaq Listing Rule 5635(c)(4).

item 3.02 item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Brad Hauser

chief executive officer and president

AMIX · Autonomix Medical, Inc.

Effective: 2024-06-17
Filed: June 17, 2024, 7:59 PM ET

entered into an employment agreement with Brad Hauser pursuant to which Mr. Hauser agreed to serve as the Company’s chief executive officer and president

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Brad Hauser was appointed as chief executive officer and president at Autonomix Medical, Inc..

Action: appointed
Role: chief executive officer and president

Exact text from the filing

entered into an employment agreement with Brad Hauser pursuant to which Mr. Hauser agreed to serve as the Company’s chief executive officer and president

View on SEC.gov

Autonomix Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-24-020534

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.